Medline Inc. Class A common stock (MDLN) Financials
Key financial figures for Medline Inc. Class A common stock (Q2 2026).
Medline Inc. reported revenue of $7.69 billion for Q2 FY2026, up 11.6% from the same period a year earlier. Net income was $60.0 million, or $0.07 per share. Operating margin came to 5.14%, against 9.13% a year earlier. Free cash flow for the period was $604.0 million. Across the last 5 reported quarters, quarterly revenue has risen from $6.89 billion in Q2 FY2025 to $7.69 billion in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Medline Inc. are on the SentiSense financials page.
- Revenue
- $7.7B
- Net Income
- $60M
- EPS
- $0.07
- Total Assets
- $39.4B
- Operating Cash Flow
- $715M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $7.7B | $60M | $0.07 | 5.14% | $604M |
| Q1 FY2026 | $7.4B | $129M | $0.16 | 5.74% | $316M |
| Q4 FY2025 | $7.8B | $180M | $0.22 | 5.46% | |
| Q3 FY2025 | $7.1B | $322M | $0.41 | 8.07% | $535M |
| Q2 FY2025 | $6.9B | $333M | $0.42 | 9.13% | $103M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $28.4B | $1.2B | $1.43 | 7.78% | $1.3B |
| FY2024 | $25.5B | $1.2B | $1.52 | 8.72% | $1.4B |
| FY2023 | $23.2B | $234M | $0.30 | 6.22% | $1.4B |
Frequently asked questions
What was Medline Inc.'s revenue last quarter?
Medline Inc. reported revenue of $7.69 billion for Q2 FY2026, up 11.6% from the same period a year earlier.
Is Medline Inc. profitable?
Yes. Medline Inc. reported net income of $60.0 million for Q2 FY2026, a net margin of 0.78% on revenue.
How has Medline Inc.'s margin trended?
Operating margin was 5.14% in Q2 FY2026, compared with 9.13% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Medline Inc. generate?
Medline Inc. generated free cash flow of $604.0 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Medline Inc. Class A common stock on SentiSense, with up to forty quarters and twenty fiscal years of history.